Table 2.
Animal groups | WT–ANG II-L (n = 6) |
WT–ANG II-L+Temp (n = 6) |
WT–ANG II-L+ETN (n = 6) |
WT–ETN (n = 6) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Day of Treatment | 0 | 7th | 13th | 0 | 7th | 13th | 0 | 7th | 13th | 0 | 7th | 13th |
Urine flow, ml/day | 1.69 ± 0.23 | 1.30 ± 0.29 | 1.60 ± 0.30 | 1.31 ± 0.14 | 1.30 ± 0.14 | 1.17 ± 0.14 | 1.74 ± 0.15 | 1.14 ± 0.17 | 1.12 ± 0.48 | 1.84 ± 0.17 | 1.15 ± 0.11 | 0.65 ± 0.13* |
UNaV, mmol/day | 0.15 ± 0.015 | 0.15 ± 0.03 | 0.12 ± 0.02 | 0.16 ± 0.01 | 0.18 ± 0.01 | 0.15 ± 0.02 | 0.20 ± 0.02 | 0.17 ± 0.03 | 0.08 ± 0.01* | 0.20 ± 0.02 | 0.17 ± 0.03 | 0.08 ± 0.01* |
UKV, mmol/day | 0.43 ± 0.13 | 0.37 ± 0.07 | 0.37 ± 0.08 | 0.31 ± 0.05 | 0.41 ± 0.04 | 0.40 ± 0.05 | 0.51 ± 0.10 | 0.29 ± 0.02 | 0.12 ± 0.03 | 0.53 ± 0.04 | 0.26 ± 0.02 | 0.70 ± 0.01 |
UNOxV, μmol/day | 0.27 ± 0.10 | 0.39 ± 0.15 | 0.74 ± 0.37* | 0.41 ± 0.09 | 0.56 ± 0.06 | 0.93 ± 0.30* | 1.25 ± 0.21 | 0.89 ± 0.35 | 0.75 ± 0.15 | 1.55 ± 0.40 | 1.81 ± 0.68 | 2.53 ± 0.57 |
UISOV, ng/day | 1.0 ± 0.2 | 1.8 ± 0.4* | 1.5 ± 0.4* | 1.9 ± 0.1 | 2.5 ± 0.6 | 2.1 ± 0.3 | 1.7 ± 0.5 | 2.1 ± 0.7 | 3.3 ± 0.9* | 1.3 ± 0.3 | 1.5 ± 0.1 | 2.3* ± 0.3 |
Temp, tempol; ETN, etanercept; UNOxV, urinary nitrate/nitrite excretion; UISOV, urinary isoprostane excretion; Temp, tempol; ETN, etanercept.
P < 0.05 vs. baseline values at −1 day.